Trust CO Of Vermont Amgen Inc Transaction History

Trust CO Of Vermont

$1.96 Billion
Q1 2025

A detailed history of Trust CO Of Vermont transactions in Amgen Inc stock. As of the latest transaction made, Trust CO Of Vermont holds 22,431 shares of AMGN stock, worth $6.24 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

22,431

Previous 23,245 3.5%

Holding current value

$6.24 Million

Previous $6.06 Million 15.35%

% of portfolio

0.36%

Previous 0.3%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$258.59 - $327.36 $210,492 - $266,471	-814 Reduced 3.5%	22,431 $6.99 Million
Q4 2024 Jan 15, 2025	BUY	$258.78 - $328.31 $9,057 - $11,490	35 Added 0.15%	23,245 $6.06 Million
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $123,442 - $134,614	-399 Reduced 1.69%	23,210 $7.48 Million
Q2 2024 Jul 09, 2024	SELL	$262.75 - $319.31 $39,675 - $48,215	-151 Reduced 0.64%	23,609 $7.38 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $1.64 Million - $1.99 Million	6,116 Added 34.66%	23,760 $6.76 Million
Q4 2023 Mar 08, 2024	SELL	$255.7 - $288.46 $1.58 Million - $1.79 Million	-6,197 Reduced 25.99%	17,644 $5.08 Million
Q3 2023 Nov 27, 2023	SELL	$218.65 - $271.46 $586,419 - $728,055	-2,682 Reduced 10.11%	23,841 $6.41 Million
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $706,019 - $834,854	-3,295 Reduced 11.05%	26,523 $5.89 Million
Q1 2023 Apr 07, 2023	SELL	$225.79 - $275.2 $50,125 - $61,094	-222 Reduced 0.74%	29,818 $7.21 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $87,718 - $111,456	383 Added 1.29%	30,040 $7.89 Million
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $296,736 - $334,664	1,322 Added 4.67%	29,657 $6.69 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $240,169 - $267,266	-1,041 Reduced 3.54%	28,335 $6.89 Million
Q1 2022 Apr 05, 2022	BUY	$219.27 - $242.57 $62,491 - $69,132	285 Added 0.98%	29,376 $7.1 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $163,877 - $187,542	-824 Reduced 2.75%	29,091 $6.55 Million
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $199,958 - $234,275	-942 Reduced 3.05%	29,915 $6.36 Million
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $16,817 - $18,658	-72 Reduced 0.23%	30,857 $7.52 Million
Q1 2021 Apr 16, 2021	SELL	$221.91 - $258.6 $67,904 - $79,131	-306 Reduced 0.98%	30,929 $7.7 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $101,265 - $120,589	468 Added 1.52%	31,235 $7.18 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $6,335 - $7,045	27 Added 0.09%	30,767 $7.82 Million
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $1.93 Million - $2.37 Million	-9,766 Reduced 24.11%	30,740 $7.25 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $34,990 - $46,406	-192 Reduced 0.47%	40,506 $8.21 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $104,633 - $134,489	-553 Reduced 1.34%	40,698 $9.81 Million
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $18,803 - $22,530	108 Added 0.26%	41,251 $7.98 Million
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $51,343 - $60,186	308 Added 0.75%	41,143 $7.58 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $97,308 - $109,687	538 Added 1.34%	40,835 $7.76 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $17,661 - $20,616	99 Added 0.25%	40,297 $7.85 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $145,452 - $163,978	785 Added 1.99%	40,198 $8.33 Million
Q2 2018 Jul 11, 2018	BUY	$166.05 - $186.51 $87,674 - $98,477	528 Added 1.36%	39,413 $7.28 Million
Q1 2018 May 18, 2018	BUY	$169.43 - $198.0 $168,752 - $197,208	996 Added 2.63%	38,885 $6.63 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $205,079 - $229,136	1,215 Added 3.31%	37,889 $6.59 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $6.14 Million - $7 Million	36,674	36,674 $6.84 Million

Others Institutions Holding AMGN

# of Institutions

3,308

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Account

Trust CO Of Vermont Amgen Inc Transaction History